Navigation Links
Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
Date:11/10/2008

ion upon the attainment of development and

regulatory milestones, plus additional undisclosed commercial milestone

payments.

-- Enrollment in CONNECTION, our confirmatory Phase 3 trial in

mild-to-moderate Alzheimer's disease, continues on track. All 30 of

our U.S. sites have been opened, and we expect the majority of our

ex-U.S. sites to be opened by the end of November. We expect to

complete enrollment of this trial in 2009.

-- Completed a randomized, double-blind safety and tolerability study of

combination therapy with Dimebon and donepezil (Aricept(R)) in patients

with Alzheimer's disease, which found the combination to be well

tolerated with no serious adverse events.

-- Plan to initiate new Phase 3 studies in 2009 to seek further

differentiation of Dimebon to include moderate-to-severe Alzheimer's

disease, adjunctive use with cholinesterase inhibitors, and

twelve-month efficacy.

-- Received a Corporate Achievement Award from the Huntington's Disease

Society of America (HDSA) for exemplifying leadership in the fight

against Huntington's disease and other neurodegenerative diseases.

-- Plan to initiate the next Huntington's disease efficacy study in 2009.

MDV3100: Drug candidate to treat castration-resistant prostate cancer

-- Presented data at the 20th EORTC-NCI-AACR Symposium on "Molecular

Targets and Cancer Therapeutics" from an ongoing open-label,

dose-escalation, U.S.-based Phase 1-2 clinical trial in prostate cancer

patients who have failed standard hormonal therapies. Results showed

encouraging and durable anti-tumor activity in the three expanded dose

groups tested thus far, as measured by prostate specific antigen (PSA)

declines, radiographic findings, circulating tumor cell (CTC) changes,

and time on treatment. MDV
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008
2. Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
3. Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients
4. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
5. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
6. Medivation Announces Participation in Upcoming Conferences
7. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
8. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
9. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
10. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
11. Medivation Announces Senior Management Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...   University of Maryland (UM) Ventures and ... of an exclusive option by Biomecite Diagnostics for the ... diagnostics to detect inflammatory bowel diseases (IBD), such as ... Florian Fricke and James White developed ... of Maryland School of Medicine,s Institute for Genome Sciences ...
(Date:5/6/2015)... May 6, 2015 ... specialist, announced today that it has signed an agreement ... PEIX ) for the delivery of an industrial scale ... the consumption of water, energy and emissions ... This project is fully aligned ...
(Date:5/5/2015)... RURO, Inc., a leading LIMS, RFID and sample ... major content upgrade to its bestselling, Commercial Off-The-Shelf (COTS) ... a significant advancement of FreezerPro® system , ... also simplifying , New FreezerPro® VM ... Download available immediately for free to “Gold” support subscribers ...
(Date:5/5/2015)... 2015  23andMe, Inc., the leading personal genetics company, ... Study in collaboration with Pfizer Inc. The companies ... more commonly known as lupus, into the study to ... is also in collaboration with the Lupus Research Institute, ... Approximately 1.5 million people in the U.S. ...
Breaking Biology Technology:Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Whitefox Signs Agreement With Pacific Ethanol Inc. 2RURO Releases version 7 of FreezerPro® software 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 3
... 6, 2011 Genprex, Inc., formerly known as ... the nanomolecular cancer therapy CNVN202, will be branded as ... Oncoprex brand in the oncology sector in recognition of ... Oncoprex will be used to unlock the unrealized potential ...
... AMSTERDAM, September 6, 2011 , Gains ... Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in ... it has entered into an exclusive license agreement with ... of adeno-associated virus serotype 5 (AAV5)-based gene therapy vectors ...
... terahertz light is invisible it,s at the farthest end ... from detecting explosives at the airport to designing drugs to ... the U.S. Department of Energy,s Lawrence Berkeley National Laboratory (Berkeley ... a microscale device made of graphene the remarkable form ...
Cached Biology Technology:Genprex Announces New Branding 2Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health 2Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health 3A whole new light on graphene metamaterials 2A whole new light on graphene metamaterials 3
(Date:4/27/2015)... 27, 2015  For more than four decades, AUVSI,s ... been the premier worldwide event for the unmanned land, ... must-attend event for any local, national, or trade news ... commercial markets and current applications of unmanned technologies. The ... projected $48 billion industry, and how it will soon ...
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
(Date:4/13/2015)...  higi, a leading cloud-based consumer engagement platform that ... with their communities around health and wellness, announced today ... API.  ... and convenient vehicle to receive validated health information from ... The API will allow higi,s trusted partners, on a ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... the Grand Canyon may be so old that dinosaurs once ... from the University of Colorado at Boulder and the California ... as radiometric dating to show the Grand Canyon may have ... assumed origins by 40 million to 50 million years. ...
... . Researchers from all over the world have ... from mouth and saliva cells to carry out the DNA ... (director of the Laboratory of Genetic Identification of the ... commissioned by the court in cases of paternity tests, for ...
... with a Canberra-based company Dyesol, which is developing transparent solar ... houses or commercial buildings. He said the solar cell ... owners energy costs and could in fact generate excess energy ... the glass was one of a number of practical technologies ...
Cached Biology News:Grand Canyon may be as old as dinosaurs, says new study 2Grand Canyon may be as old as dinosaurs, says new study 3Fraud attempt in a paternity test modifies action protocol in DNA tests 2
Active GST Protein...
Cyno macaque plasma and serum - various quantities available...
adult...
Natural Mouse Laminin is purified from the Engelbreth-Holm-Swarm (EHS) sarcoma and is provided in Tris-buffered saline....
Biology Products: